Clinical experience with infliximab and adalimumab in a single-center cohort of patients with Crohn's disease

By Riis Åse   Martinsen Tom C.   Waldum Helge L.   Fossmark Reidar  

Scandinavian Journal of Gastroenterology, Vol. 47, Iss. 6, 2012-06 ,pp. : 649-657

Informa Healthcare

Access to resources Recommend Favorite

Short- and Long-Term Outcomes of Infliximab Treatment for Steroid-Refractory Ulcerative Colitis and Related Prognostic Factors: A Single-Center Retrospective Study

By  

Digestion, Vol. 95, Iss. 1, 2017-01 ,pp. : 67-71

Karger

Access to resources Recommend Favorite

Incidence, Clinical Characteristics, Long-Term Course, and Comparison of Progressive and Nonprogressive Cases of Aphthous-Type Crohn's Disease: A Single-Center Cohort Study

By  

Digestion, Vol. 87, Iss. 4, 2013-06 ,pp. : 262-268

Karger

Access to resources Recommend Favorite

Impact of Metabolic Syndrome on the Hospitalization Rate of Crohn's Disease Patients Seen at a Tertiary Care Center: A Retrospective Cohort Study

By  

Digestion, Vol. 91, Iss. 3, 2015-03 ,pp. : 257-262

Karger

Access to resources Recommend Favorite

Therapeutic efficacy of infliximab on active Crohn's disease under nutritional therapy

By Matsumoto Takayuki   Iida Mitsuo   Kohgo Yutaka   Imamura Akimichi   Kusugami Kazuo   Nakano Hiroshi   Fujiyama Yoshihide   Matsu Toshiyuki   Hibi Toshifumi  

Scandinavian Journal of Gastroenterology, Vol. 40, Iss. 12, 2005-12 ,pp. : 1423-1430

Informa Healthcare

Access to resources Recommend Favorite